| Wai Ping Chan, DO | |
|
13633 37th Ave Ste 4a, Flushing, NY 11354 | |
| (718) 762-6462 | |
| (187) 509-6467 |
| Full Name | Wai Ping Chan |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 18 Years |
| Location | 13633 37th Ave Ste 4a, Flushing, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033354428 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 250588 (New York) | Primary |
| Entity Name | North Shore - Lij Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053688572 PECOS PAC ID: 3375701568 Enrollment ID: O20120220000262 |
News Archive
High eye pressure is the leading risk factor for glaucoma, and is the only modifiable one. If glaucoma is untreated, vision loss may continue, leading to blindness in some individuals.
Insurers' profits are a lightning rod for reform advocates. Aetna's earnings have now attracted reprimand from Senate Democrats who say the major insurance company overstated it spending on patient care in regulatory filings, minimizing profits and overhead, The Wall Street Journal reports.
In his latest Kaiser Health News column, Timothy Jost writes that the development of this draft rule is not a contest with winners and losers, but an effort to create a framework to press insurers to spend less money on bureaucracy and more on health care in a way that benefits consumers and keeps insurance markets viable (9/30).
b3 bio inc. today announced that it has signed an agreement with Roche to source and develop innovative early stage technologies that could result in potential therapeutic benefits for patients. Roche will have certain rights for further development and/or commercialization of such technologies. As part of this agreement, Roche will increase its equity investment in b3 bio as well as providing development funds.
› Verified 3 days ago
| Entity Name | Inspira Dermatology Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255862025 PECOS PAC ID: 4981968732 Enrollment ID: O20180503001075 |
News Archive
High eye pressure is the leading risk factor for glaucoma, and is the only modifiable one. If glaucoma is untreated, vision loss may continue, leading to blindness in some individuals.
Insurers' profits are a lightning rod for reform advocates. Aetna's earnings have now attracted reprimand from Senate Democrats who say the major insurance company overstated it spending on patient care in regulatory filings, minimizing profits and overhead, The Wall Street Journal reports.
In his latest Kaiser Health News column, Timothy Jost writes that the development of this draft rule is not a contest with winners and losers, but an effort to create a framework to press insurers to spend less money on bureaucracy and more on health care in a way that benefits consumers and keeps insurance markets viable (9/30).
b3 bio inc. today announced that it has signed an agreement with Roche to source and develop innovative early stage technologies that could result in potential therapeutic benefits for patients. Roche will have certain rights for further development and/or commercialization of such technologies. As part of this agreement, Roche will increase its equity investment in b3 bio as well as providing development funds.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wai Ping Chan, DO 13633 37th Ave Ste 4a, Flushing, NY 11354-4562 Ph: (718) 762-6462 | Wai Ping Chan, DO 13633 37th Ave Ste 4a, Flushing, NY 11354 Ph: (718) 762-6462 |
News Archive
High eye pressure is the leading risk factor for glaucoma, and is the only modifiable one. If glaucoma is untreated, vision loss may continue, leading to blindness in some individuals.
Insurers' profits are a lightning rod for reform advocates. Aetna's earnings have now attracted reprimand from Senate Democrats who say the major insurance company overstated it spending on patient care in regulatory filings, minimizing profits and overhead, The Wall Street Journal reports.
In his latest Kaiser Health News column, Timothy Jost writes that the development of this draft rule is not a contest with winners and losers, but an effort to create a framework to press insurers to spend less money on bureaucracy and more on health care in a way that benefits consumers and keeps insurance markets viable (9/30).
b3 bio inc. today announced that it has signed an agreement with Roche to source and develop innovative early stage technologies that could result in potential therapeutic benefits for patients. Roche will have certain rights for further development and/or commercialization of such technologies. As part of this agreement, Roche will increase its equity investment in b3 bio as well as providing development funds.
› Verified 3 days ago
Julie Zang, M.D., PH.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3808 Union St, Ste 3f, Flushing, NY 11354 Phone: 646-872-7148 | |
Dr. Robert Tankel, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 157 15 46th Ave, Flushing, NY 11355 Phone: 718-886-6663 Fax: 718-886-2681 | |
Dr. Stephanie W. Hu, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 14472 Northern Blvd Ste 203, Flushing, NY 11354 Phone: 718-886-9000 | |
Dimitris C Zouzias, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3202 Union St, Flushing, NY 11354 Phone: 718-445-1550 Fax: 718-445-2843 | |
Dr. Jian Cui, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 13620 38th Ave, Suite 5h, Flushing, NY 11354 Phone: 718-661-9554 Fax: 718-661-9556 | |
Hyun-soo Lee, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 14472 Northern Blvd Ste 203, Flushing, NY 11354 Phone: 718-886-9000 |